Page last updated: 2024-11-11

manoalide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

manoalide: phospholipase A2 inhibitor; sesterterpene from marine sponge L. variabilis; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

manoalide : A sesterterpenoid isolated from the marine sponge Luffariella variabilis and which has been shown to exhibit inhibitory activity towards phospholipase A2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6437368
CHEMBL ID463914
CHEBI ID66666
SCHEMBL ID20551728
MeSH IDM0132711

Synonyms (25)

Synonym
manoalide
2(5h)-furanone, 4-((2r,6r)-3,6-dihydro-6-hydroxy-5-((3e)-4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-hexenyl)-2h-pyran-2-yl)-5-hydroxy-, (5r)-
2(5h)-furanone, 4-(3,6-dihydro-6-hydroxy-5-(4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-hexenyl)-2h-pyran-2-yl)-5-hydroxy-
5-hydroxy-4-{(r)-6-hydroxy-5-[(e)-4-methyl-6-(2,6,6-trimethyl-cyclohex-1-enyl)-hex-3-enyl]-3,6-dihydro-2h-pyran-2-yl}-5h-furan-2-one
bdbm50250399
75088-80-1
CHEMBL463914 ,
chebi:66666 ,
(2r)-2-hydroxy-3-[(2r,6r)-6-hydroxy-5-[(e)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hex-3-enyl]-3,6-dihydro-2h-pyran-2-yl]-2h-furan-5-one
(2r)-3-[(2r,6r)-5-[(e)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hex-3-enyl]-6-oxidanyl-3,6-dihydro-2h-pyran-2-yl]-2-oxidanyl-2h-furan-5-one
(2r)-2-hydroxy-3-[(2r,6r)-6-hydroxy-5-[(e)-4-methyl-6-(2,6,6-trimethyl-1-cyclohexenyl)hex-3-enyl]-3,6-dihydro-2h-pyran-2-yl]-2h-furan-5-one
A838321
C17156
(5r)-5-hydroxy-4-{(2r,6r)-6-hydroxy-5-[(3e)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]-3,6-dihydro-2h-pyran-2-yl}furan-2(5h)-one
e1dk0157k9 ,
unii-e1dk0157k9
(5r)-5-hydroxy-4-((2r,6r)-6-hydroxy-5-((e)-4-methyl-6-(2,6,6-trimethyl-1-cyclohexenyl)hex-3-enyl)-3,6-dihydro-2h-pyran-2-yl)-5h-furan-2-one
hmp linker?4-(hydroxymethyl) phenoxyacetic acid
SCHEMBL20551728
Q10853851
AT25841
CS-0129960
DTXSID401028174
HY-N7487
2(5h)-furanone, 4-[(2r,6r)-3,6-dihydro-6-hydroxy-5-[(3e)-4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-hexen-1-yl]-2h-pyran-2-yl]-5-hydroxy-, (5r)-

Research Excerpts

Overview

Manoalide is a potent analgesic and antiinflammatory sesterterpene isolated in 1980 from a marine sponge. It has anti-inflammatory and anti-proliferative activities and is an irreversible inhibitor of phospholipases A2 and C.

ExcerptReferenceRelevance
"Manoalide is a potent analgesic and antiinflammatory sesterterpene isolated in 1980 from a marine sponge. "( Manoalide.
Alcaraz, MJ; De Rosa, MM; PayĆ”, M; Scettri, A; Sodano, G; Soriente, A; Terencio, MC, 1999
)
3.19
"Manoalide is a marine natural product that has anti-inflammatory and anti-proliferative activities and is an irreversible inhibitor of phospholipase A2 and phospholipase C. "( Manoalide, a natural sesterterpenoid that inhibits calcium channels.
De Vries, G; Goodrum, D; Muallem, S; Sachs, G; Wheeler, LA; Woldemussie, E, 1987
)
3.16
"Manoalide is a potent antiinflammatory marine natural product and a direct inactivator of venom phospholipase A2 (PLA2; EC 3.1.1.4). "( Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
de Carvalho, MS; Faulkner, DJ; Glaser, KB; Jacobs, RS; Kernan, MR, 1989
)
3.16
"Manoalide is a novel sesterterpenoid which has previously been shown to be a potent inhibitor of venom phospholipases A2. "( Inhibition of phosphoinositide-specific phospholipase C by manoalide.
Bennett, CF; Clark, MA; Crooke, ST; Mong, S; Wheeler, L; Wu, HL, 1987
)
1.96

Effects

Manoalide has been shown to irreversibly inhibit PLA2. It also has the ability to inhibit the ATPase activity of human DHX36/RHAU, a putative RNA helicase.

ExcerptReferenceRelevance
"Manoalide (1) also has the ability to inhibit the ATPase activity of human DHX36/RHAU, a putative RNA helicase."( Inhibition of hepatitis C virus NS3 helicase by manoalide.
Akimitsu, N; Furuta, A; Moriishi, K; Nakakoshi, M; Noda, N; Salam, KA; Sekiguchi, Y; Tanaka, J; Tani, H; Tsubuki, M; Tsuneda, S; Yamashita, A, 2012
)
1.36
"Many manoalide analogues have been isolated from marine sponges, most of them sharing PLA2 inhibitory properties."( Manoalide.
Alcaraz, MJ; De Rosa, MM; PayĆ”, M; Scettri, A; Sodano, G; Soriente, A; Terencio, MC, 1999
)
2.2
"Manoalide has been shown to irreversibly inhibit PLA2, with the corresponding modification of a selective number of lysine residues."( Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
de Carvalho, MS; Faulkner, DJ; Glaser, KB; Jacobs, RS; Kernan, MR, 1989
)
2.44

Treatment

ExcerptReferenceRelevance
"Pretreatment with manoalide (0.3 mg/joint) significantly inhibited PLA2 activity in the synovial fluid, prevented the loss of proteoglycan from the condylar cartilage, and reduced proteoglycan levels in lavage fluids."( The effects of the phospholipase A2 inhibitor, manoalide, on cartilage degradation, stromelysin expression, and synovial fluid cell count induced by intraarticular injection of human recombinant interleukin-1 alpha in the rabbit.
Finkel, M; Flory, CM; Jacobson, PB; Kuchera, SL; Lesch, ME; Schrier, DJ, 1996
)
0.87
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
EC 3.1.1.4 (phospholipase A2) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of phospholipase A2 (EC 3.1.1.4).
EC 5.99.1.2 (DNA topoisomerase) inhibitorA topoisomerase inhibitor that inhibits the bacterial enzymes of the DNA topoisomerases, Type I class (EC 5.99.1.2) that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. These bacterial enzymes reduce the topological stress in the DNA structure by relaxing negatively, but not positively, supercoiled DNA.
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitorA topoisomerase inhibitor that inhibits DNA topoisomerase (ATP-hydrolysing), EC 5.99.1.3 (also known as topoisomerase II and as DNA gyrase), which catalyses ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
butenolideA gamma-lactone that consists of a 2-furanone skeleton and its substituted derivatives.
lactolCyclic hemiacetals formed by intramolecular addition of a hydroxy group to an aldehydic or ketonic carbonyl group. They are thus 1-oxacycloalkan-2-ols or unsaturated analogues.
sesterterpenoidAny terpenoid derived from a sesterterpene. The term includes compounds in which the C25 skeleton of the parent sesterterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups). Sometimes sesterterpenoids are erroneously referred to as sesterpenoids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (10)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Phosphatidylcholine 2-acylhydrolase Apis mellifera (honey bee)IC50 (µMol)0.04000.04000.11330.2300AID359617
Acidic phospholipase A2 betaCrotalus adamanteus (eastern diamondback rattlesnake)IC50 (µMol)0.40000.40000.40000.4000AID379558
Phospholipase A2Apis mellifera (honey bee)IC50 (µMol)13.35710.07003.85707.5000AID158767; AID360344; AID400706; AID401446; AID401447; AID497174; AID568203
Phospholipase A2Homo sapiens (human)IC50 (µMol)3.90000.00300.91223.9000AID400710
Phospholipase A2, membrane associatedRattus norvegicus (Norway rat)IC50 (µMol)1,019.20000.12000.12000.1200AID159104; AID401444
Phospholipase A2, membrane associatedHomo sapiens (human)IC50 (µMol)320.98000.00301.08118.0000AID158938; AID158948; AID360342; AID401442; AID401443
Mu-type opioid receptorCavia porcellus (domestic guinea pig)IC50 (µMol)0.50000.00020.660310.0000AID497174
Platelet-activating factor acetylhydrolaseHomo sapiens (human)IC50 (µMol)3.90000.00000.38373.9000AID158948
DNA polymerase kappaHomo sapiens (human)IC50 (µMol)4.50003.40005.95009.2000AID1315755; AID1315756
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (53)

Processvia Protein(s)Taxonomy
positive regulation of interleukin-8 productionPhospholipase A2Homo sapiens (human)
positive regulation of MAP kinase activityPhospholipase A2Homo sapiens (human)
innate immune response in mucosaPhospholipase A2Homo sapiens (human)
neutrophil mediated immunityPhospholipase A2Homo sapiens (human)
fatty acid biosynthetic processPhospholipase A2Homo sapiens (human)
actin filament organizationPhospholipase A2Homo sapiens (human)
signal transductionPhospholipase A2Homo sapiens (human)
positive regulation of cell population proliferationPhospholipase A2Homo sapiens (human)
positive regulation of calcium ion transport into cytosolPhospholipase A2Homo sapiens (human)
lipid catabolic processPhospholipase A2Homo sapiens (human)
leukotriene biosynthetic processPhospholipase A2Homo sapiens (human)
antibacterial humoral responsePhospholipase A2Homo sapiens (human)
neutrophil chemotaxisPhospholipase A2Homo sapiens (human)
activation of phospholipase A2 activityPhospholipase A2Homo sapiens (human)
cellular response to insulin stimulusPhospholipase A2Homo sapiens (human)
intracellular signal transductionPhospholipase A2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPhospholipase A2Homo sapiens (human)
regulation of glucose importPhospholipase A2Homo sapiens (human)
phosphatidylcholine metabolic processPhospholipase A2Homo sapiens (human)
phosphatidylglycerol metabolic processPhospholipase A2Homo sapiens (human)
positive regulation of fibroblast proliferationPhospholipase A2Homo sapiens (human)
arachidonic acid secretionPhospholipase A2Homo sapiens (human)
positive regulation of protein secretionPhospholipase A2Homo sapiens (human)
positive regulation of immune responsePhospholipase A2Homo sapiens (human)
defense response to Gram-positive bacteriumPhospholipase A2Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityPhospholipase A2Homo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptidePhospholipase A2Homo sapiens (human)
positive regulation of podocyte apoptotic processPhospholipase A2Homo sapiens (human)
phospholipid metabolic processPhospholipase A2Homo sapiens (human)
phospholipid metabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
inflammatory responsePhospholipase A2, membrane associatedHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPhospholipase A2, membrane associatedHomo sapiens (human)
lipid catabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
killing of cells of another organismPhospholipase A2, membrane associatedHomo sapiens (human)
low-density lipoprotein particle remodelingPhospholipase A2, membrane associatedHomo sapiens (human)
intestinal stem cell homeostasisPhospholipase A2, membrane associatedHomo sapiens (human)
phosphatidylethanolamine metabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
phosphatidylcholine metabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
phosphatidic acid metabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
arachidonic acid secretionPhospholipase A2, membrane associatedHomo sapiens (human)
positive regulation of inflammatory responsePhospholipase A2, membrane associatedHomo sapiens (human)
defense response to Gram-positive bacteriumPhospholipase A2, membrane associatedHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadePhospholipase A2, membrane associatedHomo sapiens (human)
regulation of neutrophil activationPhospholipase A2, membrane associatedHomo sapiens (human)
negative regulation of T cell proliferationPhospholipase A2, membrane associatedHomo sapiens (human)
peptide hormone processingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
low-density lipoprotein particle remodelingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
lipid oxidationPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
plasma lipoprotein particle oxidationPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
phosphatidylcholine catabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
platelet activating factor metabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
positive regulation of inflammatory responsePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
platelet activating factor catabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
positive regulation of monocyte chemotaxisPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
DNA replicationDNA polymerase kappaHomo sapiens (human)
DNA repairDNA polymerase kappaHomo sapiens (human)
nucleotide-excision repair, DNA gap fillingDNA polymerase kappaHomo sapiens (human)
DNA damage responseDNA polymerase kappaHomo sapiens (human)
cellular response to UVDNA polymerase kappaHomo sapiens (human)
error-prone translesion synthesisDNA polymerase kappaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
phospholipase A2 activityPhospholipase A2Homo sapiens (human)
signaling receptor bindingPhospholipase A2Homo sapiens (human)
calcium ion bindingPhospholipase A2Homo sapiens (human)
bile acid bindingPhospholipase A2Homo sapiens (human)
calcium-dependent phospholipase A2 activityPhospholipase A2Homo sapiens (human)
phospholipid bindingPhospholipase A2Homo sapiens (human)
phospholipase A2 activityPhospholipase A2, membrane associatedHomo sapiens (human)
phospholipid bindingPhospholipase A2, membrane associatedHomo sapiens (human)
calcium-dependent phospholipase A2 activityPhospholipase A2, membrane associatedHomo sapiens (human)
calcium ion bindingPhospholipase A2, membrane associatedHomo sapiens (human)
1-alkyl-2-acetylglycerophosphocholine esterase activityPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
phospholipid bindingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
hydrolase activity, acting on ester bondsPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
calcium-independent phospholipase A2 activityPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
damaged DNA bindingDNA polymerase kappaHomo sapiens (human)
metal ion bindingDNA polymerase kappaHomo sapiens (human)
DNA-directed DNA polymerase activityDNA polymerase kappaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (16)

Processvia Protein(s)Taxonomy
extracellular regionPhospholipase A2Homo sapiens (human)
extracellular spacePhospholipase A2Homo sapiens (human)
cell surfacePhospholipase A2Homo sapiens (human)
extracellular regionPhospholipase A2, membrane associatedHomo sapiens (human)
extracellular spacePhospholipase A2, membrane associatedHomo sapiens (human)
mitochondrial outer membranePhospholipase A2, membrane associatedHomo sapiens (human)
endoplasmic reticulumPhospholipase A2, membrane associatedHomo sapiens (human)
endoplasmic reticulum membranePhospholipase A2, membrane associatedHomo sapiens (human)
plasma membranePhospholipase A2, membrane associatedHomo sapiens (human)
secretory granulePhospholipase A2, membrane associatedHomo sapiens (human)
perinuclear region of cytoplasmPhospholipase A2, membrane associatedHomo sapiens (human)
extracellular exosomePhospholipase A2, membrane associatedHomo sapiens (human)
extracellular regionPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
low-density lipoprotein particlePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
high-density lipoprotein particlePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
site of DNA damageDNA polymerase kappaHomo sapiens (human)
nucleusDNA polymerase kappaHomo sapiens (human)
nucleoplasmDNA polymerase kappaHomo sapiens (human)
nuclear bodyDNA polymerase kappaHomo sapiens (human)
nucleusDNA polymerase kappaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (55)

Assay IDTitleYearJournalArticle
AID666932Inhibition of HCV NS3 binding to human 5'-[32Pgamma]-labelled lethal-7 microRNA precursor ssRNA at 0.1 mM after 15 mins by PAGE analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Inhibition of hepatitis C virus NS3 helicase by manoalide.
AID666933Inhibition of HCV NS3 ATPase activity using [32Pgamma]ATP as substrate at 0.1 mM after 60 mins by thin layer chromatography analysis in the absence of poly(U)RNA2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Inhibition of hepatitis C virus NS3 helicase by manoalide.
AID158770Inhibitory activity against bee secretory Phospholipase A2 enzyme at 10 uM1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID666930Noncompetitive inhibition of HCV NS3 ATPase activity using 1 to 8 mM [32gamma]ATP at 0.1 mM by Lineweaver-Burk plot analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Inhibition of hepatitis C virus NS3 helicase by manoalide.
AID337877Cytotoxicity against mouse L1210 cells1993Journal of natural products, Mar, Volume: 56, Issue:3
Luffariolides F and G, new manoalide derivatives from the Okinawan marine sponge Luffariella sp.
AID360347Inhibition of group 4 cytosolic phospholipase A2 in mouse RAW264.7 cells at 10 uM2001Journal of natural products, May, Volume: 64, Issue:5
New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.
AID666929Inhibition of HCV NS3 ATPase activity using [32gamma]ATP as substrate after 30 mins by thin layer chromatography analysis in the presence of poly(U)RNA2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Inhibition of hepatitis C virus NS3 helicase by manoalide.
AID360342Inhibition of human synovial recombinant group 2 secretory phospholipase A2 by liquid scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.
AID336281Inhibition of PLA2 activity at 4 uM1992Journal of natural products, Jul, Volume: 55, Issue:7
Homoscalarane sesterterpenes from Lendenfeldia frondosa.
AID401444Inhibition of rat air pouch group2 sPLA2 at 10 uM by liquid scintillation counting1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID568203Inhibition of bee venom phospholipase A2 after 5 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Feb-15, Volume: 21, Issue:4
Chemical and biological explorations of the electrophilic reactivity of the bioactive marine natural product halenaquinone with biomimetic nucleophiles.
AID400706Inhibition of bee venom secretory PLA21998Journal of natural products, May, Volume: 61, Issue:5
Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra.
AID158771Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated for 15 minutes1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID401439Inhibition of Naja naja venom group1 sPLA2 at 10 uM by liquid scintillation counting1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID159104In vitro inhibition of rat secretory Phospholipase A2 (group II).1996Journal of medicinal chemistry, Dec-20, Volume: 39, Issue:26
Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.
AID401440Inhibition of pig pancreatic group1 sPLA2 at 10 uM by liquid scintillation counting1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID1315755Inhibition of human DNA polymerase kappa (19 to 526 residues) preincubated for 15 mins followed by replicating non-damaged DNA substrate addition measured after 30 mins in presence of dCTP and dGTP by radioactive gel-based primer extension assay2016Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics.
AID158774Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated with Hydroxylamine for 15 minutes1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID158938In vitro inhibition of human recombinant secretory Phospholipase A2 (group II).1996Journal of medicinal chemistry, Dec-20, Volume: 39, Issue:26
Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.
AID360338Inhibition of Naja naja venom group 1 secretory phospholipase A2 at 10 uM by liquid scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.
AID401441Inhibition of pig pancreatic group1 sPLA2 by liquid scintillation counting1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID158777Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated with Tris buffer for 15 minutes1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID360339Inhibition of pig pancreatic group 1 secretory phospholipase A2 at 10 uM by liquid scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.
AID158772Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated for 5 minutes1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID158779Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated with Tris buffer for 60 minutes1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID158948Inhibitory activity against human synovial recombinant Phospholipase enzyme1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID158778Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated with Tris buffer for 5 minutes1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID497174Inhibition of bee venom phospholipase A2 after 5 mins by spectrophotometric analysis2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
New bioactive halenaquinone derivatives from South Pacific marine sponges of the genus Xestospongia.
AID158767Inhibitory activity against bee secretory Phospholipase A2 enzyme1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID360341Inhibition of human synovial recombinant group 2 secretory phospholipase A2 at 10 uM by liquid scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.
AID401445Inhibition of rat air pouch group2 sPLA2 by liquid scintillation counting1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID158776Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated with Hydroxylamine for 60 minutes1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID666934Binding affinity to HCV NS3 helicase assessed as increase in fluorescence after 15 mins by isothermal denaturation assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Inhibition of hepatitis C virus NS3 helicase by manoalide.
AID158950Inhibitory activity against human synovial Phospholipase at 10 uM1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID666927Inhibition of HCV NS3 RNA helicase activity using [32P]-dsRNA as substrate measured every 5 secs for 5 mins and every 30 secs up to 30 mins by photoinduced electron transfer-based fluorescence assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Inhibition of hepatitis C virus NS3 helicase by manoalide.
AID401447Inhibition of bee venom group3 sPLA2 by liquid scintillation counting1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID401443Inhibition of human synovial group2 sPLA2 by liquid scintillation counting1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID337878Cytotoxicity against human KB cells1993Journal of natural products, Mar, Volume: 56, Issue:3
Luffariolides F and G, new manoalide derivatives from the Okinawan marine sponge Luffariella sp.
AID405549Inhibition of bovine pancreas PLA2 at 100 uM by pH-stat assay2008Journal of natural products, Jun, Volume: 71, Issue:6
Aplysinoplides A-C, cytotoxic sesterterpenes from the marine sponge Aplysinopsis digitata.
AID354826Antiinflammatory activity in mouse assessed as inhibition of phorbol myristyl palmitate-induced ear edema per ear after 200 mins1996Journal of natural products, Aug, Volume: 59, Issue:8
Tolypodiol, an antiinflammatory diterpenoid from the cyanobacterium Tolypothrix nodosa.
AID359617Inhibition of bee venom PLA21992Journal of natural products, Dec, Volume: 55, Issue:12
Phospholipase A2 inhibitors from marine organisms.
AID158773Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated for 60 minutes1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID158775Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated with Hydroxylamine for 5 minutes1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID666928Inhibition of HCV NS3 RNA helicase activity using [32Pgamma]-labelled partial duplex RNA as substrate incubated for 15 mins prior to ATP addition measured after 30 mins by PAGE analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Inhibition of hepatitis C virus NS3 helicase by manoalide.
AID401442Inhibition of human synovial group2 sPLA2 at 10 uM by liquid scintillation counting1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID379558Inhibition of Crotalus adamanteus venom phospholipase A2 by fluorometric assay2006Journal of natural products, Dec, Volume: 69, Issue:12
Hyrtiazepine, an azepino-indole-type alkaloid from the Red Sea marine sponge Hyrtios erectus.
AID401446Inhibition of bee venom group3 sPLA2 at 10 uM by liquid scintillation counting1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID1315756Inhibition of human DNA polymerase kappa (19 to 526 residues)-mediated TLS past acrolein derived ring-opened reduced form of gamma-HOPdG lesions preincubated for 15 mins followed by DNA substrate addition measured after 30 mins in presence of dCTP and dGT2016Journal of medicinal chemistry, Oct-27, Volume: 59, Issue:20
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics.
AID159107Inhibitory activity against naja naja secretory Phospholipase A2 at 10 uM1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID360343Inhibition of bee venom group 3 secretory phospholipase A2 at 10 uM by liquid scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.
AID360344Inhibition of bee venom group 3 secretory phospholipase A2 by liquid scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.
AID159092Inhibitory activity against Porcine pancreatic secretory Phospholipase A2 at 10 uM1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
AID666931Inhibition of human DHX36/RHAU ATPase activity using [32Pgamma]ATP as substrate for 30 mins in the presence of poly(U)RNA2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Inhibition of hepatitis C virus NS3 helicase by manoalide.
AID401448Cytotoxicity against human neutrophils by MTT assay1998Journal of natural products, Jul, Volume: 61, Issue:7
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
AID400710Inhibition of human synovial secretory PLA21998Journal of natural products, May, Volume: 61, Issue:5
Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (110)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (14.55)18.7374
1990's53 (48.18)18.2507
2000's24 (21.82)29.6817
2010's12 (10.91)24.3611
2020's5 (4.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.28 (24.57)
Research Supply Index4.75 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (5.22%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other109 (94.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]